Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Withdrawn 1Unknown 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 2Genitourinary 1

Conditions

Thyroid Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Prostatic Neoplasms 1Hypothyroidism 1

Interventions

Cyclophosphamide 2064Radiotherapy 1984Cisplatin 1851Carboplatin 1557Gemcitabine 1452Paclitaxel 1320Bevacizumab 1316pembrolizumab 1235Docetaxel 1225Oxaliplatin 1181Capecitabine 1173Fluorouracil 1081Dexamethasone 979Magnetic Resonance Spectroscopy 967Nivolumab 936Rituximab 928Drug Therapy 911Surveys and Questionnaires 898Doxorubicin 845Etoposide 843Radiosurgery 814Blood Specimen Collection 814Irinotecan 783Cytarabine 743fludarabine 723Leucovorin 682Surgical Procedures, Operative 638Lenalidomide 618Biopsy 592fludarabine phosphate 568

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Coffee × Clear all
NCT05478239 2026-02-05

ArtemiCoffee in Patients With Rising PSA

University of Kentucky

Phase 2 Active not recruiting
20 enrolled
Genitourinary

Prostatic Neoplasms

NCT01707056 2021-02-17

The Effect of Coffee on the Absorption of Thyroid Hormone in Patients With Thyroid Carcinoma

Medstar Health Research Institute

Phase NA Withdrawn
Head & Neck

Hypothyroidism, Thyroid Neoplasms

NCT03619304 2019-01-30

Assessment of Anti-cancerous Effect of Green, Roasted and Decaffeinated Coffee on Oral Squamous Cell Carcinoma Cell Line

Cairo University

Phase NA Unknown
20 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡